Artelo Biosciences, Inc. Common Stock ARTL

$7.31 +76.14% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K FORM 8-K 2026-08-27 View →
10-Q FORM 10-Q 2026-08-12 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
4 FORM 4 2026-07-21 View →
8-K FORM 8-K 2026-07-17 View →
DEF 14A DEF 14A 2026-06-05 View →
8-K FORM 8-K 2026-05-27 View →
424B5 424B5 2026-05-26 View →
424B5 FORM 424B5 2026-05-18 View →
8-K FORM 8-K 2026-05-15 View →
10-Q FORM 10-Q 2026-05-14 View →
S-3 FORM S-3 2026-05-04 View →
S-1 FORM S-1 2026-04-07 View →
8-K FORM 8-K 2026-04-07 View →
8-K FORM 8-K 2026-03-30 View →
8-K FORM 8-K 2026-03-26 View →
S-1 FORM S-1 2026-03-24 View →
S-1 FROM-S-1 2026-03-20 View →
8-K FORM 8-K 2026-03-18 View →
8-K FORM 8-K 2026-03-17 View →
8-K FORM 8-K 2026-03-06 View →
10-K FORM 10-K 2026-02-24 View →
8-K FORM 8-K 2026-02-05 View →
8-K FORM 8-K 2026-02-05 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
4 FORM 4 2026-02-02 View →
8-K FORM 8-K 2026-01-30 View →
8-K FORM 8-K 2026-01-16 View →
8-K FORM 8-K 2026-01-02 View →
DEF 14A DEF 14A 2025-12-11 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$7.31
Market Cap
$2.27 million
52-Week Range
$3.45 – $270.00
Average Volume
945K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.